E8 MedTech distinguishes itself as an innovative distributor of Medical Devices and Supplies, proudly standing as a certified Federal Contractor and National Minority Supplier of OEM Personal Protective Equipment (PPE) and essential commodities. At the forefront of the PPE industry, E8 MedTech is dedicated to offering advanced solutions tailored to the evolving global marketplace.

Our company excels in supplying a broad range of medical equipment and essential products to a diverse clientele, including government institutions, diagnostic testing facilities, hospitals, professional sports leagues, and various private sector organizations.

As a privately held entity, E8 MedTech collaborates with renowned manufacturers such as Celltrion, GenBody, Healgen, Access Bio, and Best-Rx to distribute premium PPE products. In an industry characterized by rapid transformation, our mission revolves around perpetually innovating and enhancing our offerings to meet the dynamic challenges head-on.

E8 MedTech's strategic approach marries cutting-edge technology and scientific insight with a deep understanding of our customer's needs, ensuring we meet and exceed the expectations of those we serve in the healthcare field.

PPE KIT

CUSTOM KIT INCLUDES

3x 3 Ply Disposable Facial Mask

1x 60ML Hand Sanitizer (62% Alcohol)

3x Hand Wipes (70% Alcohol)

The BEST-Rx 3Ply facial masks come with a pliable nosepiece for a more comfortable fit. This PPE KIT is an example of a custom order KIT.

Please CONTACT US with PPE product inquires

GenBody Rapid
COVID-19 Ag Test (POC)

GenBody Rapid COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen.

Product
Specification:

FDA EUA Authorized rapid antigen test
Anterior nasal swab specimen collection for comfort
Identifies acute infection with a 92.31% sensitivity and 99.04 specificity
Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test
Large manufacturing capacity and immediately available for distribution
For use in the Point-of-Care setting

Intended Use:

GenBody Rapid COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor-binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen.

This product has not been FDA cleared or approved, but has been authorized by FDA under a EUA for use by authorized laboratories;
This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens and,
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1) unless the declaration is terminated or authorization is revoked sooner